Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK(R)). - Duvic,M.; Kuzel,T.M.; Olsen,E.A.; Martin,A.G.; Foss,F.M.; Kim,Y.H.; Heald,P.W.; Bacha,P.; Nichols,J.; Liepa,A. (Clin Lymphoma, 2002)